54.17
price up icon0.09%   0.05
pre-market  プレマーケット:  55.37   1.20   +2.22%
loading
前日終値:
$54.12
開ける:
$54.16
24時間の取引高:
944.97K
Relative Volume:
0.69
時価総額:
$5.24B
収益:
$7.50M
当期純損益:
$-383.17M
株価収益率:
-11.51
EPS:
-4.7048
ネットキャッシュフロー:
$-307.84M
1週間 パフォーマンス:
-0.40%
1か月 パフォーマンス:
-4.38%
6か月 パフォーマンス:
+31.61%
1年 パフォーマンス:
+77.66%
1日の値動き範囲:
Value
$53.86
$55.35
1週間の範囲:
Value
$52.85
$55.80
52週間の値動き範囲:
Value
$28.19
$63.95

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
名前
Xenon Pharmaceuticals Inc
Name
セクター
Healthcare (1106)
Name
電話
(604) 484-3300
Name
住所
200 - 3650 GILMORE WAY, BURNABY
Name
職員
370
Name
Twitter
Name
次回の収益日
2026-05-07
Name
最新のSEC提出書
Name
XENE's Discussions on Twitter

Compare XENE vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
XENE icon
XENE
Xenon Pharmaceuticals Inc
54.17 5.23B 7.50M -383.17M -307.84M -4.7048
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
434.52 110.03B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
638.88 67.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
806.46 50.76B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
297.45 40.12B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
151.56 32.68B 742.00K -1.37B -1.07B -7.0731

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-02-24 開始されました Wolfe Research Outperform
2025-09-03 再開されました Wells Fargo Overweight
2025-05-07 開始されました Chardan Capital Markets Buy
2025-02-11 開始されました Deutsche Bank Buy
2024-10-10 再開されました Raymond James Outperform
2024-10-01 開始されました H.C. Wainwright Buy
2024-01-04 開始されました Citigroup Buy
2023-12-08 開始されました Robert W. Baird Outperform
2023-10-24 再開されました Cantor Fitzgerald Overweight
2023-04-25 開始されました Cantor Fitzgerald Overweight
2022-12-14 開始されました Goldman Buy
2022-12-12 開始されました Cowen Outperform
2022-11-28 開始されました Wells Fargo Overweight
2022-10-19 開始されました Raymond James Outperform
2022-08-29 開始されました BofA Securities Buy
2022-07-21 開始されました JP Morgan Overweight
2021-10-28 開始されました RBC Capital Mkts Outperform
2020-10-02 開始されました SVB Leerink Outperform
2020-07-21 開始されました Needham Buy
2020-06-01 再開されました Jefferies Buy
2020-03-25 開始されました Wedbush Outperform
2020-01-08 開始されました William Blair Outperform
2019-09-20 開始されました Guggenheim Buy
2018-08-08 繰り返されました Stifel Buy
2017-03-13 開始されました Jefferies Buy
2016-10-21 開始されました Stifel Buy
2016-09-26 開始されました Guggenheim Buy
2016-04-14 繰り返されました Jefferies Buy
2015-10-30 再開されました Jefferies Buy
2014-12-02 開始されました Canaccord Genuity Buy
すべてを表示

Xenon Pharmaceuticals Inc (XENE) 最新ニュース

pulisher
May 22, 2026

JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE) - Insider Monkey

May 22, 2026
pulisher
May 22, 2026

Xenon Pharmaceuticals Inc.Common Shares (NQ: XENE - The Chronicle-Journal

May 22, 2026
pulisher
May 22, 2026

XENE Stock Price, Quote & Chart | XENON PHARMACEUTICALS INC (NASDAQ:XENE) - ChartMill

May 22, 2026
pulisher
May 21, 2026

5 Best Performing Canadian Stocks So Far in 2026 - Insider Monkey

May 21, 2026
pulisher
May 21, 2026

A Look At Xenon Pharmaceuticals (XENE) Valuation After Strong Long Term Returns And Recent Momentum Cooldown - Sahm

May 21, 2026
pulisher
May 20, 2026

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing - AOL.com

May 20, 2026
pulisher
May 19, 2026

Which Is a Better Investment, Sarepta Therapeutics, Inc. or Xenon Pharmaceuticals Inc. Stock? - AAII

May 19, 2026
pulisher
May 18, 2026

Xenon Q1 earnings match estimates, pipeline development in focus - MSN

May 18, 2026
pulisher
May 18, 2026

Xenon Pharmaceuticals stock (CA98420N1050): epilepsy data and capital raise put biotech in focus - AD HOC NEWS

May 18, 2026
pulisher
May 18, 2026

DNB Asset Management AS Acquires 23,750 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat

May 18, 2026
pulisher
May 16, 2026

(XENE) Volatility Zones as Tactical Triggers - Stock Traders Daily

May 16, 2026
pulisher
May 15, 2026

Janus Henderson reports 4.5% stake in Xenon Pharmaceuticals (XENE) filing - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Xenon Pharmaceuticals (NASDAQ: XENE) shows 5.78M-share holding, 6.26% - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Driehaus files Schedule 13G/A disclosing 4.87% in Xenon (XENE) - Stock Titan

May 15, 2026
pulisher
May 14, 2026

XENE: Azetukalner’s strong efficacy and novel mechanism set the stage for a major epilepsy market launch - TradingView

May 14, 2026
pulisher
May 14, 2026

Xenon Pharmaceuticals stock (CA98420N1050): Director exercises options for 3,500 shares - AD HOC NEWS

May 14, 2026
pulisher
May 13, 2026

Xenon Pharmaceuticals (XENE) director exercises options, now holds 10,641 shares - Stock Titan

May 13, 2026
pulisher
May 13, 2026

XENE Stock Chart | XENON PHARMACEUTICALS INC (NASDAQ:XENE) - ChartMill

May 13, 2026
pulisher
May 12, 2026

XENE Maintained by JP Morgan -- Price Target Raised to $80.00 - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan - Moomoo

May 12, 2026
pulisher
May 12, 2026

Xenon anticipates AZK NDA in Q3 2026 amid launch timing at end of 2027 or early 2028 - MSN

May 12, 2026
pulisher
May 12, 2026

Equities Analysts Set Expectations for XENE Q2 Earnings - MarketBeat

May 12, 2026
pulisher
May 11, 2026

A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase 3 X TOLE2 Success And Extended Cash Runway - Yahoo Finance

May 11, 2026
pulisher
May 11, 2026

Insiders At Xenon Pharmaceuticals Sold US$1.0m In Stock, Alluding To Potential Weakness - Moomoo

May 11, 2026
pulisher
May 11, 2026

Did Positive X-TOLE2 Data and a Major Cash Raise Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative? - Yahoo Finance

May 11, 2026
pulisher
May 10, 2026

Nan Fung Trinity HK Ltd. Has $10.17 Million Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

May 10, 2026
pulisher
May 09, 2026

A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $63 to $80.65 - Moomoo

May 09, 2026
pulisher
May 09, 2026

Xenon Pharmaceuticals Q1 earnings call highlights - MSN

May 09, 2026
pulisher
May 09, 2026

Xenon Pharmaceuticals Q1 Earnings Call Highlights - sharewise.com

May 09, 2026
pulisher
May 08, 2026

Xenon Pharmaceuticals Maps Path After Standout XTOL-2 - TipRanks

May 08, 2026
pulisher
May 08, 2026

Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus - Yahoo Finance

May 08, 2026
pulisher
May 08, 2026

RBC Capital Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $82 - Moomoo

May 08, 2026
pulisher
May 08, 2026

Needham Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Cuts Target Price to $78 - Moomoo

May 08, 2026
pulisher
May 08, 2026

A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $74 to $80.65 - Moomoo

May 08, 2026
pulisher
May 08, 2026

Xenon Pharmaceuticals (XENE) Achieves Milestones Ahead of FDA Su - GuruFocus

May 08, 2026
pulisher
May 08, 2026

Xenon Pharmaceuticals 1Q Rev $0.00 >XENE - Moomoo

May 08, 2026
pulisher
May 07, 2026

William Blair Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Announces Target Price $80.65 - Moomoo

May 07, 2026
pulisher
May 07, 2026

Earnings call transcript: Xenon Pharmaceuticals Q1 2026 results show mixed signals - Investing.com Nigeria

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals Q1 Loss Widens - Moomoo

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q1 Per Share Loss $1.17, vs. FactSet Est of Loss $1.18 - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals (NASDAQ:XENE) Reports Mixed Q1 Results as Azetukalner Nears FDA Submission - ChartMill

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals (XENE) deepens Q1 loss but amasses $1.34B cash war chest - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals: Q1 Earnings Snapshot - kare11.com

May 07, 2026
pulisher
May 07, 2026

A seizure drug filing is next, but Xenon has 5 more Phase 3 studies running - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals Inc. (XENE) Latest Stock News & Headlines - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Xenon Reports Q1 2026 Financial Results and Provides Business Update - The Manila Times

May 07, 2026
pulisher
May 07, 2026

Big cash raise and strong Phase 3 results headline Xenon (XENE) Q1 2026 - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals Q1 2026 Earnings Call Transcript - MarketBeat

May 07, 2026
pulisher
May 07, 2026

Xenon Pharmaceuticals faces earnings test as launch nears - Investing.com UK

May 07, 2026

Xenon Pharmaceuticals Inc (XENE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$29.96
price down icon 2.98%
$106.24
price down icon 3.00%
$92.14
price up icon 1.33%
$54.50
price up icon 1.77%
ONC ONC
$310.25
price up icon 0.20%
$151.56
price down icon 1.41%
大文字化:     |  ボリューム (24 時間):